Published in Law and Health Weekly, October 1st, 2005
After analysis of available scientific and clinical data, including those of a prospective randomized multicenter study, BUPA, the leading private healthcare insurance provider in the U.K. has recognized this procedure for use on its members when performed by a consultant who has been specifically trained by St. Francis Medical Technologies.
Based on the scientific proof of efficacy and unique characteristics of the implant, the coding was issued by CCSD, the U.K. private health...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.